2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones
    1.
    发明授权
    2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones 失效
    2-取代的1H-苯并[d] {{{{{(异喹啉-1,3(2H) - 二酮)

    公开(公告)号:US4115555A

    公开(公告)日:1978-09-19

    申请号:US812886

    申请日:1977-07-05

    CPC分类号: C07D221/14 C07H19/048

    摘要: Compounds of the following formula ##STR1## wherein R.sup.1 and R.sup.2 are independently selected from hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio, nitro, cyano, and trifluoromethyl, and R is selected from a triacetyl substituted pentose, pentose, a tetraacetyl substituted hexose, hexose, a hydroxy substituted cycloalkyl of 5 to 7 carbons, ##STR2## wherein n is 1 or 2 ad R.sup.3 is hydrogen, an alkali metal or alkaline earth metal ion; are disclosed. These compounds possess useful anti-inflammatory activity.

    摘要翻译: 下式的化合物其中R 1和R 2独立地选自氢,卤素,低级烷基,低级烷氧基,低级烷硫基,硝基,氰基和三氟甲基,R选自三乙酰基取代的戊糖,戊糖,四乙酰 取代的己糖,己糖,5至7个碳的羟基取代的环烷基,其中n为1或2,R 3为氢,碱金属或碱土金属离子; 被披露。 这些化合物具有有用的抗炎活性。

    Various 2-(substituted piperazinyl)-1H-benz [de]isoquinoline-1,3 (2H)
-diones
    2.
    发明授权
    Various 2-(substituted piperazinyl)-1H-benz [de]isoquinoline-1,3 (2H) -diones 失效
    各种2-(取代的哌嗪基)-1H-苯并[{[{{{{{(异喹啉-1,3(2H) - 二酮)

    公开(公告)号:US4070465A

    公开(公告)日:1978-01-24

    申请号:US699723

    申请日:1976-06-24

    CPC分类号: C07D221/14

    摘要: Compounds of the following formula and their acid addition salts ##STR1## Z is ##STR2## A is straight or branched chain alkylene of 2 to 6 carbons; B is straight chain alkylene of 2 to 4 carbons; X is straight or branched chain alkyl of 1 to 8 carbons, phenyl, benzyl, phenethyl, substituted phenyl, substituted benzyl, or substituted phenethyl, R.sub.1 and R.sub.2 are located at the 7 or 8 and 5 or 6 position respectively and are independently selected from the group consisting of hydrogen, straight or branched chain alkyl of 1 to 4 carbons, straight or branched chain alkoxy of 1 to 4 carbons, Cl, Br, F, amino, nitro, CF.sub.3, and cyano; are disclosed. These compounds possess antiprotozoal activity.

    摘要翻译: 下式的化合物及其酸加成盐:A是2至6个碳的直链或支链亚烷基; B是2至4个碳的直链亚烷基; X是1至8个碳的直链或支链烷基,苯基,苄基,苯乙基,取代的苯基,取代的苄基或取代的苯乙基,R1和R2分别位于7或8和5或6位,并且独立地选自 由氢,1至4个碳的直链或支链烷基,1至4个碳的直链或支链烷氧基,Cl,Br,F,氨基,硝基,CF 3和氰基组成的组; 被披露。 这些化合物具有抗原虫活性。

    N-(1-(1,3-D
ihydro-1,3-dioxo-2H-benz(de)-isoquinolin-2-yl)alkyl)-4-N-piperidinyl)-n-p
henylalkylamides
    4.
    发明授权
    N-(1-(1,3-D ihydro-1,3-dioxo-2H-benz(de)-isoquinolin-2-yl)alkyl)-4-N-piperidinyl)-n-p henylalkylamides 失效
    N-(1-(1,3-二氢-1,3-二氧代-2H-苯并(de) - 异喹啉-2-基)烷基)-4-N-哌啶基)-N-苯基烷基酰胺

    公开(公告)号:US3959286A

    公开(公告)日:1976-05-25

    申请号:US538977

    申请日:1975-01-06

    IPC分类号: C07D221/14 C07D401/06

    CPC分类号: C07D221/14 C07D401/06

    摘要: Compounds of the following formula and their acid addition salts ##SPC1##Wherein R.sup.1 and R.sup.2 are independently selected from hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio, nitro, cyano, amino and trifluoromethyl; A is a straight or branched chain alkylene of 1 to 8 carbons; R.sup.3 is phenyl or substituted phenyl; and R is lower alkyl or cycloalkyl of 3 to 7 carbons are disclosed. These compounds exhibit antidepressant activity. In addition these compounds are useful as antiinflammatory agents.

    摘要翻译: 下式的化合物及其酸加成盐,其中R1和R2独立地选自氢,卤素,低级烷基,低级烷氧基,低级烷硫基,硝基,氰基,氨基和三氟甲基; A是1至8个碳的直链或支链亚烷基; R3是苯基或取代的苯基; 并且R是3至7个碳的低级烷基或环烷基。 这些化合物显示抗抑郁活性。 此外,这些化合物可用作抗炎剂。

    2-[(Substituted
piperazinyl)alkyl]-2,3-dihydro-3-hydroxy-1H-benz[de]isoquinolin-1-ones
    5.
    发明授权
    2-[(Substituted piperazinyl)alkyl]-2,3-dihydro-3-hydroxy-1H-benz[de]isoquinolin-1-ones 失效
    2- {8(取代的哌嗪基)烷基{9 -2,3-二氢-3-羟基-1H-苯并[{[{{

    公开(公告)号:US4077958A

    公开(公告)日:1978-03-07

    申请号:US718225

    申请日:1976-08-27

    CPC分类号: C07D221/14

    摘要: Compounds of the following formula ##STR1## wherein R.sup.1 and R.sup.2 are selected from hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogen, trifluoromethyl, nitro, amino and cyano; Z is selected from ##STR2## R.sup.3 is selected from phenyl, phenyl-lower alkyl, substituted phenyl, and substituted phenyl-lower alkyl; R.sup.4 is selected from R.sup.3 and a 6-membered unsaturated substituted or unsubstituted heterocyclic ring selected from pyridine, diazine and triazine; and A is a straight or branched chain alkylene of 2 to 8 carbons are disclosed. These compounds exhibit antidepressant activity.

    摘要翻译: 下式的化合物其中R 1和R 2选自氢,低级烷基,低级烷氧基,低级烷硫基,卤素,三氟甲基,硝基,氨基和氰基; Z选自 R3选自苯基,苯基 - 低级烷基,取代的苯基和取代的苯基 - 低级烷基; R4选自R3和选自吡啶,二嗪和三嗪的6元不饱和取代或未取代的杂环; 并且A是2至8个碳的直链或支链亚烷基。 这些化合物显示抗抑郁活性。

    2-(Piperidinyl or
tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin
-1-ones
    6.
    发明授权
    2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin -1-ones 失效
    -2-(哌啶基或四氢吡啶基) - 烷基)-2,3-二氢-3-羟基-1H-苯并(DE)异喹啉-1-酮

    公开(公告)号:US4007191A

    公开(公告)日:1977-02-08

    申请号:US621939

    申请日:1975-10-14

    CPC分类号: C07D221/14

    摘要: Compounds of the following formula ##STR1## wherein R.sup.1 and R.sup.2 are selected from hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogen, trifluoromethyl, nitro, amino and cyano; Z is selected from ##STR2## R.sup.3 is selected from phenyl, phenyl-lower alkyl, substituted phenyl, and substituted phenyl-lower alkyl; R.sup.4 is selected from R.sup.3 and a 6-membered unsaturated substituted or unsubstituted heterocyclic ring selected from pyridine, diazine and triazine; and A is a straight or branched chain alkylene of 2 to 8 carbons are disclosed. These compounds exhibit antidepressant activity.

    摘要翻译: 下式的化合物其中R 1和R 2选自氢,低级烷基,低级烷氧基,低级烷硫基,卤素,三氟甲基,硝基,氨基和氰基; Z选自 R3选自苯基,苯基 - 低级烷基,取代的苯基和取代的苯基 - 低级烷基; R4选自R3和选自吡啶,二嗪和三嗪的6元不饱和取代或未取代的杂环; 并且A是2至8个碳的直链或支链亚烷基。 这些化合物显示抗抑郁活性。

    2-[(Substituted-piperidinyl or
tetrahydropyridinyl)alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
    8.
    发明授权
    2-[(Substituted-piperidinyl or tetrahydropyridinyl)alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones 失效
    2- {8(取代的哌啶基或四氢吡啶基)烷基{9-1H-苯并[{[{{{{{异喹啉-1,3(2H)

    公开(公告)号:US3935227A

    公开(公告)日:1976-01-27

    申请号:US501411

    申请日:1974-08-28

    摘要: Compounds of the following formula and their acid addition salts ##SPC1##Wherein R.sup.1 and R.sup.2 are independently selected from hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio, nitro, cyano, amino and trifluoromethyl; A is a straight or branched chain alkylene of 1 to 8 carbons; and Z is selected from ##SPC2##Wherein R.sup.3 is selected from phenyl, phenyl-lower alkyl, and substituted phenyl and phenyl-lower alkyl are disclosed. These compounds exhibit antidepressant and anti-anxiety activity. In addition these compounds are useful as anti-inflammatory agents.

    摘要翻译: 下式的化合物及其酸加成盐,其中R1和R2独立地选自氢,卤素,低级烷基,低级烷氧基,低级烷硫基,硝基,氰基,氨基和三氟甲基; A是1至8个碳的直链或支链亚烷基; 并且Z选自其中R 3选自苯基,苯基 - 低级烷基和取代的苯基和苯基 - 低级烷基。 这些化合物显示抗抑郁和抗焦虑活性。 此外,这些化合物可用作抗炎剂。

    Various 2-substituted-1H-benz[de]isoquinoline-1,3(2H)-diones
    9.
    发明授权
    Various 2-substituted-1H-benz[de]isoquinoline-1,3(2H)-diones 失效
    各种2-取代的1H-苯并[{[{{{{{异喹啉-1,3(2H) - 二酮}

    公开(公告)号:US4062953A

    公开(公告)日:1977-12-13

    申请号:US699724

    申请日:1976-06-24

    CPC分类号: C07D401/06 A61K31/47

    摘要: Compounds of the following formula and their acid addition salts ##STR1## A is straight or branched chain alkylene of 2 to 6 carbons; R.sub.1 and R.sub.2 are located at the 7 or 8 and 5 or 6 position respectively and are independently selected from the group consisting of hydrogen, straight or branched chain alkyl of 1 to 4 carbons, straight or branched chain alkoxy of 1 to 4 carbons, Cl, Br, F, amino, nitro, cyano, and CF.sub.3 ; R.sub.3 and R.sub.4 are independently selected from the group consisting of hydrogen and straight or branched chain alkyl of 1 to 4 carbons; and n is 1, 2, or 3; m is 1 or 2; are disclosed. These compounds possess anti-protozoal activity.

    摘要翻译: 下式的化合物及其酸加成盐A是2至6个碳的直链或支链亚烷基; R1和R2分别位于7或8和5或6位,并且独立地选自氢,1至4个碳的直链或支链烷基,1至4个碳的直链或支链烷氧基,Cl ,Br,F,氨基,硝基,氰基和CF 3; R 3和R 4独立地选自氢和1至4个碳的直链或支链烷基; n为1,2或3; m为1或2; 被披露。 这些化合物具有抗原生动物活性。

    3-[Substituted-2-(methylamino) phenyl]-4-[2-oxo-2-(hetero-cyclic)
ethyl]-5-substituted-1,2,4-triazoles
    10.
    发明授权
    3-[Substituted-2-(methylamino) phenyl]-4-[2-oxo-2-(hetero-cyclic) ethyl]-5-substituted-1,2,4-triazoles 失效
    3- {8取代的2-(甲基氨基)苯基{9-4 {8 2-氧代-2-(杂环)){9-5-取代-1,2,4-三唑

    公开(公告)号:US4020064A

    公开(公告)日:1977-04-26

    申请号:US680315

    申请日:1976-04-26

    摘要: Compounds of the following formula and their pharmaceutically acceptable salts ##STR1## wherein R.sub.1 and R.sub.4 are the same or different and are each a five or six membered N containing heterocycle attached at an available N atom; R.sub.2 is hydrogen, alkyl, trifluoromethyl, phenyl, benzyl, --(CH.sub.2).sub.n --R.sub.4 or --(CH.sub.2).sub.n --N(alkyl).sub.2 ; R.sub.3 is hydrogen, halogen, nitro, trifluoromethyl, alkyl, alkoxy, or alkylthio; and n is an integer from 1 to 4; are disclosed. These compounds are useful as anti-inflammatory agents.

    摘要翻译: 下式的化合物及其药学上可接受的盐,其中R 1和R 4相同或不同,并且各自为在可用的N原子上连接的5或6元N的杂环; R 2是氢,烷基,三氟甲基,苯基,苄基, - (CH 2)n -R 4或 - (CH 2)n -N(烷基)2; R3是氢,卤素,硝基,三氟甲基,烷基,烷氧基或烷硫基; n为1〜4的整数。 被披露。 这些化合物可用作抗炎剂。